Effects of triparanol administration on certain aspects of protein and steroid metabolism, serum lipids and lipoproteins.
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000328:Adult; D003480:Cushing Syndrome / Q000188:drug therapy; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008055:Lipids; D008074:Lipoproteins; D008297:Male; D008875:Middle Aged; D011506:Proteins / Q000378:metabolism*; D013256:Steroids / Q000378:metabolism*; D014308:Triparanol / Q000009:adverse effects / Q000494:pharmacology*; D014556:Urine
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D008055:Lipids; D008074:Lipoproteins; D011506:Proteins; D013256:Steroids; D014308:Triparanol